These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15131539)

  • 21. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of either or both left and right bundle branch block at baseline or during follow-up for predicting death in patients following acute myocardial infarction.
    Bogale N; Orn S; James M; McCarroll K; de Luna AB; Dickstein K;
    Am J Cardiol; 2007 Mar; 99(5):647-50. PubMed ID: 17317365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
    Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
    Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bedside programmed ventricular stimulation for sudden death risk stratification.
    Fuenmayor AJ; Landaeta C; Peraza F; Fuenmayor AM
    Int J Cardiol; 2004 Oct; 97(1):69-72. PubMed ID: 15336809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men: the Paris Prospective Study I.
    Empana JP; Ducimetiere P; Charles MA; Jouven X
    Circulation; 2004 Nov; 110(18):2781-5. PubMed ID: 15492315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.
    Straus SM; Kors JA; De Bruin ML; van der Hooft CS; Hofman A; Heeringa J; Deckers JW; Kingma JH; Sturkenboom MC; Stricker BH; Witteman JC
    J Am Coll Cardiol; 2006 Jan; 47(2):362-7. PubMed ID: 16412861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
    Davis DR; Krahn AD; Tang AS; Lemery R; Green MS; Gollob M; Yee R; Skanes AC; Klein GJ; Birnie DH
    Can J Cardiol; 2005 Apr; 21(5):413-7. PubMed ID: 15861258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal and cardiac functions as prognostic factors after revascularization for myocardial infarction].
    Reibis R; Herbstleb J; Kamke W; Dissmann R; Wegscheider K; Völler H
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1259-63. PubMed ID: 17541867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.
    Pedersen OD; Abildstrøm SZ; Ottesen MM; Rask-Madsen C; Bagger H; Køber L; Torp-Pedersen C;
    Eur Heart J; 2006 Feb; 27(3):290-5. PubMed ID: 16267070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
    J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children.
    Biederman J; Thisted RA; Greenhill LL; Ryan ND
    J Clin Psychiatry; 1995 Mar; 56(3):87-93. PubMed ID: 7883735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
    Yap YG; Duong T; Bland JM; Malik M; Torp-Pederson C; Køber L; Connolly SJ; Gallagher MM; Camm AJ
    J Hypertens; 2007 Feb; 25(2):307-13. PubMed ID: 17211237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
    Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
    Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].
    Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M
    Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
    Buxton AE; Lee KL; Hafley GE; Pires LA; Fisher JD; Gold MR; Josephson ME; Lehmann MH; Prystowsky EN;
    J Am Coll Cardiol; 2007 Sep; 50(12):1150-7. PubMed ID: 17868806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.